Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s share price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.01 and traded as high as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 328,147 shares traded.
Evofem Biosciences Stock Performance
The stock’s fifty day moving average price is $0.01 and its two-hundred day moving average price is $0.01. The company has a market cap of $1.19 million, a P/E ratio of -0.02 and a beta of -1.13.
Evofem Biosciences Company Profile
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Further Reading
- Five stocks we like better than Evofem Biosciences
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- How to Invest in Insurance Companies: A Guide
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- How to trade penny stocks: A step-by-step guide
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
